Robert Hilgraf

Bristol-Myers Squibb (Germany) — Germany

Chemistry · Physical Sciences

19h-index6.7kcitations40works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asymmetric Hydrogenation and Catalysis(13), Asymmetric Synthesis and Catalysis(11), Chemical Synthesis and Analysis(10), Click Chemistry and Applications(8), Melanoma and MAPK Pathways(6)

Publications40 total

Structure-based optimization of aminothiadiazole inhibitors of AKT
Medicinal Chemistry Research·2023
Discovery of the c-Jun N-Terminal Kinase Inhibitor <b>CC-90001</b>
Journal of Medicinal Chemistry·2021· 35 citedOpen Access
Discovery of a First-in-Class Inhibitor of the PRMT5–Substrate Adaptor Interaction
Journal of Medicinal Chemistry·2021· 52 citedOpen Access
High Throughput Screen Identifies Interferon γ-Dependent Inhibitors of <i>Toxoplasma gondii</i> Growth
ACS Infectious Diseases·2018· 10 citedOpen Access
High throughput screen identifies IFN-γ-dependent inhibitors of <i>Toxoplasma gondii</i> growth
2018Open Access
Stereoselective synthesis of<i>trans</i>-fused iridoid lactones and their identification in the parasitoid wasp<i>Alloxysta victrix</i>, Part II: Iridomyrmecins
Beilstein Journal of Organic Chemistry·2012· 15 citedOpen Access
Stereoselective synthesis of <i>trans</i>-fused iridoid lactones and their identification in the parasitoid wasp <i>Alloxysta victrix</i>, Part I: Dihydronepetalactones
Beilstein Journal of Organic Chemistry·2012· 20 citedOpen Access
Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor
Bioorganic & Medicinal Chemistry Letters·2011· 113 citedOpen Access
Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury
Bioorganic & Medicinal Chemistry Letters·2011· 36 citedOpen Access
Crystal Structure of JNK3 complexed with CC-930, an orally active anti-fibrotic JNK inhibitor
2011
Crystal Structure of JNK3 complexed with CC-359, a JNK inhibitor for the prevention of ischemia-reperfusion injury
2011
Discovery and optimization of thieno[2,3-d]pyrimidines as B-Raf inhibitors
Bioorganic & Medicinal Chemistry Letters·2011· 19 citedOpen Access
Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth
Molecular and Cellular Biochemistry·2009· 32 cited
ChemInform Abstract: Chiral Bis(N‐arylamino)phosphine‐oxazolines: Synthesis and Application in Asymmetric Catalysis.
ChemInform·2008
Chiral Bis(<i>N</i>‐arylamino)phosphine‐oxazolines: Synthesis and Application in Asymmetric Catalysis
Advanced Synthesis & Catalysis·2008· 42 cited
ChemInform Abstract: Enantioselective Catalytic Formation of Quaternary Stereogenic Centers
ChemInform·2008
Enantioselective Catalytic Formation of Quaternary Stereogenic Centers
European Journal of Organic Chemistry·2007· 543 cited
Osmium‐Catalyzed Olefin Dihydroxylation and Aminohydroxylation in the Second Catalytic Cycle.
ChemInform·2006
Osmium‐Catalyzed Olefin Dihydroxylation and Aminohydroxylation in the Second Catalytic Cycle
Advanced Synthesis & Catalysis·2006· 27 cited
CCDC 267259: Experimental Crystal Structure Determination
The Cambridge Structural Database·2006Open Access
page 1 of 2Next →

Frequent Co-authors

Nici Zimmermann(11), Andreas Pfaltz(11), Valery V. Fokin(8), Pier Giorgio Cozzi(8), Sogole Bahmanyar(6), K. Barry Sharpless(5), Lisa Nadolny(5), Mercedes Delgado(5), Brydon L. Bennett(5), Jason D. Katz(5), Brent Benish(5), Kate Blease(5), Heather K. Raymon(5), Brian E. Cathers(5), Steven S. Clareen(4), Ronald Albers(4), Jonathan Wright(4), Meg McCarrick(4), Philip P. Chamberlain(4), Jeff Muir(4)